(19)
(11) EP 1 140 143 A2

(12)

(88) Date of publication A3:
14.09.2000

(43) Date of publication:
10.10.2001 Bulletin 2001/41

(21) Application number: 99965894.1

(22) Date of filing: 16.12.1999
(51) International Patent Classification (IPC)7A61K 38/21, A61K 31/7056, A61P 31/14
(86) International application number:
PCT/US9927/935
(87) International publication number:
WO 0037/110 (29.06.2000 Gazette 2000/26)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 18.12.1998 US 215876

(71) Applicant: SCHERING CORPORATION
KenilworthNew Jersey 07033 (US)

(72) Inventors:
  • GLUE, Paul, W.
    Flemington, NJ 08822 (US)
  • ALBRECHT, Janice, K.
    Winter Park, FL 32789 (US)

(74) Representative: Ritter, Stephen David et al
Mathys & Squire100 Gray's Inn Road
London WC1X 8AL
London WC1X 8AL (GB)

   


(54) RIBAVIRIN-PEGYLATED INTERFERON ALFA INDUCTION HCV COMBINATION THERAPY